Exposing the Three-Dimensional Biogeography and Metabolic States of Pathogens in Cystic Fibrosis Sputum via Hydrogel Embedding, Clearing, and rRNA Labeling

ABSTRACT Physiological resistance to antibiotics confounds the treatment of many chronic bacterial infections, motivating researchers to identify novel therapeutic approaches. To do this effectively, an understanding of how microbes survive in vivo is needed. Though much can be inferred from bulk approaches to characterizing complex environments, essential information can be lost if spatial organization is not preserved. Here, we introduce a tissue-clearing technique, termed MiPACT, designed to retain and visualize bacteria with associated proteins and nucleic acids in situ on various spatial scales. By coupling MiPACT with hybridization chain reaction (HCR) to detect rRNA in sputum samples from cystic fibrosis (CF) patients, we demonstrate its ability to survey thousands of bacteria (or bacterial aggregates) over millimeter scales and quantify aggregation of individual species in polymicrobial communities. By analyzing aggregation patterns of four prominent CF pathogens, Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus sp., and Achromobacter xylosoxidans, we demonstrate a spectrum of aggregation states: from mostly single cells (A. xylosoxidans), to medium-sized clusters (S. aureus), to a mixture of single cells and large aggregates (P. aeruginosa and Streptococcus sp.). Furthermore, MiPACT-HCR revealed an intimate interaction between Streptococcus sp. and specific host cells. Lastly, by comparing standard rRNA fluorescence in situ hybridization signals to those from HCR, we found that different populations of S. aureus and A. xylosoxidans grow slowly overall yet exhibit growth rate heterogeneity over hundreds of microns. These results demonstrate the utility of MiPACT-HCR to directly capture the spatial organization and metabolic activity of bacteria in complex systems, such as human sputum. IMPORTANCE The advent of metagenomic and metatranscriptomic analyses has improved our understanding of microbial communities by empowering us to identify bacteria, calculate their abundance, and profile gene expression patterns in complex environments. We are still technologically limited, however, in regards to the many questions that bulk measurements cannot answer, specifically in assessing the spatial organization of microbe-microbe and microbe-host interactions. Here, we demonstrate the power of an enhanced optical clearing method, MiPACT, to survey important aspects of bacterial physiology (aggregation, host interactions, and growth rate), in situ, with preserved spatial information when coupled to rRNA detection by HCR. Our application of MiPACT-HCR to cystic fibrosis patient sputum revealed species-specific aggregation patterns, yet slow growth characterized the vast majority of bacterial cells regardless of their cell type. More broadly, MiPACT, coupled with fluorescent labeling, promises to advance the direct study of microbial communities in diverse environments, including microbial habitats within mammalian systems. The advent of metagenomic and metatranscriptomic analyses has improved our understanding of microbial communities by empowering us to identify bacteria, calculate their abundance, and profile gene expression patterns in complex environments. We are still technologically limited, however, in regards to the many questions that bulk measurements cannot answer, specifically in assessing the spatial organization of microbe-microbe and microbe-host interactions. Here, we demonstrate the power of an enhanced optical clearing method, MiPACT, to survey important aspects of bacterial physiology (aggregation, host interactions, and growth rate), in situ, with preserved spatial information when coupled to rRNA detection by HCR. Our application of MiPACT-HCR to cystic fibrosis patient sputum revealed species-specific aggregation patterns, yet slow growth characterized the vast majority of bacterial cells regardless of their cell type. More broadly, MiPACT, coupled with fluorescent labeling, promises to advance the direct study of microbial communities in diverse environments, including microbial habitats within mammalian systems.

[1]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[2]  M. Parkins,et al.  Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[3]  Niles A. Pierce,et al.  Next-Generation in Situ Hybridization Chain Reaction: Higher Gain, Lower Cost, Greater Durability , 2014, ACS nano.

[4]  Robert M. Dirks,et al.  Triggered amplification by hybridization chain reaction. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Parsek,et al.  Bacterial biofilms: an emerging link to disease pathogenesis. , 2003, Annual review of microbiology.

[6]  R. Amann,et al.  Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations , 1990, Applied and environmental microbiology.

[7]  Susan Murray,et al.  Decade-long bacterial community dynamics in cystic fibrosis airways , 2012, Proceedings of the National Academy of Sciences.

[8]  J. Inácio,et al.  Use of Fluorescence In Situ Hybridization for Rapid Identification of Staphylococci in Blood Culture Samples Collected in a Portuguese Hospital , 2008, Journal of Clinical Microbiology.

[9]  Aliza K Fink,et al.  The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry. , 2016, Annals of the American Thoracic Society.

[10]  S. Thiel,et al.  Cystic Fibrosis Sputum DNA Has NETosis Characteristics and Neutrophil Extracellular Trap Release Is Regulated by Macrophage Migration-Inhibitory Factor , 2014, Journal of Innate Immunity.

[11]  M. Konstan,et al.  Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. , 1994, American journal of respiratory and critical care medicine.

[12]  Forest Rohwer,et al.  Biogeochemical Forces Shape the Composition and Physiology of Polymicrobial Communities in the Cystic Fibrosis Lung , 2014, mBio.

[13]  N. Høiby,et al.  Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients , 2009, Pediatric pulmonology.

[14]  S. Molin,et al.  Phenotypes of Non-Attached Pseudomonas aeruginosa Aggregates Resemble Surface Attached Biofilm , 2011, PloS one.

[15]  Barbara A. Bailey,et al.  Clinical Insights from Metagenomic Analysis of Sputum Samples from Patients with Cystic Fibrosis , 2013, Journal of Clinical Microbiology.

[16]  Aaron S. Andalman,et al.  Structural and molecular interrogation of intact biological systems , 2013, Nature.

[17]  M. Tunney,et al.  Molecular detection of CF lung pathogens: Current status and future potential , 2013, Journal of Cystic Fibrosis.

[18]  Michael J. Sweredoski,et al.  SutA is a bacterial transcription factor expressed during slow growth in Pseudomonas aeruginosa , 2016, Proceedings of the National Academy of Sciences.

[19]  G. Rogers,et al.  Characterization of Bacterial Community Diversity in Cystic Fibrosis Lung Infections by Use of 16S Ribosomal DNA Terminal Restriction Fragment Length Polymorphism Profiling , 2004, Journal of Clinical Microbiology.

[20]  S. Molin,et al.  In Situ Growth Rates and Biofilm Development of Pseudomonas aeruginosa Populations in Chronic Lung Infections , 2007, Journal of bacteriology.

[21]  Thomas S. Lawson,et al.  In Silico Evaluation and Testing of Fluorescence In Situ Hybridization 16S rRNA Probes for Staphylococcus aureus , 2011 .

[22]  T. Scheike,et al.  Polymorphonuclear Leukocytes Restrict Growth of Pseudomonas aeruginosa in the Lungs of Cystic Fibrosis Patients , 2014, Infection and Immunity.

[23]  O. Maaløe,et al.  Dependency on medium and temperature of cell size and chemical composition during balanced grown of Salmonella typhimurium. , 1958, Journal of general microbiology.

[24]  P. Hugenholtz,et al.  Numbers and locations of native bacteria on field-grown wheat roots quantified by fluorescence in situ hybridization (FISH). , 2006, Environmental microbiology.

[25]  D. Newman,et al.  Pediatric Cystic Fibrosis Sputum Can Be Chemically Dynamic, Anoxic, and Extremely Reduced Due to Hydrogen Sulfide Formation , 2015, mBio.

[26]  M. Surette,et al.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients , 2008, Proceedings of the National Academy of Sciences.

[27]  Charless C. Fowlkes,et al.  Whole-body tissue stabilization and selective extractions via tissue-hydrogel hybrids for high-resolution intact circuit mapping and phenotyping , 2015, Nature Protocols.

[28]  Paul Stoodley,et al.  Evolving concepts in biofilm infections , 2009, Cellular microbiology.

[29]  Matthew R. Parsek,et al.  Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms , 2000, Nature.

[30]  Alexander Rokitansky,et al.  Thorax , 2009, Pediatric Surgery Digest.

[31]  J. Nielsen,et al.  Identification of glucose-fermenting bacteria in a full-scale enhanced biological phosphorus removal plant by stable isotope probing. , 2012, Microbiology.

[32]  Forest Rohwer,et al.  Spatial distribution of microbial communities in the cystic fibrosis lung , 2011, The ISME Journal.

[33]  Johannes E. Schindelin,et al.  The ImageJ ecosystem: An open platform for biomedical image analysis , 2015, Molecular reproduction and development.

[34]  C. Wolz,et al.  Adaptation of Staphylococcus aureus to the cystic fibrosis lung. , 2010, International journal of medical microbiology : IJMM.

[35]  Thomas Bjarnsholt,et al.  The in vivo biofilm. , 2013, Trends in microbiology.

[36]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[37]  W. Manz,et al.  Multivariate analysis of microbial communities in the River Elbe (Germany) on different phylogenetic and spatial levels of resolution. , 2006, FEMS microbiology ecology.

[38]  M. Lethem,et al.  The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum. , 1990, The European respiratory journal.

[39]  L. Cariani,et al.  Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols , 2012, Thorax.

[40]  J. Heesemann,et al.  Specific and Rapid Detection by Fluorescent In Situ Hybridization of Bacteria in Clinical Samples Obtained from Cystic Fibrosis Patients , 2000, Journal of Clinical Microbiology.

[41]  J. Kitzman,et al.  Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis Lungs. , 2015, Cell host & microbe.

[42]  G. O’Toole,et al.  Innate and induced resistance mechanisms of bacterial biofilms. , 2008, Current topics in microbiology and immunology.

[43]  M. Hatamoto,et al.  In situ DNA-hybridization chain reaction (HCR): a facilitated in situ HCR system for the detection of environmental microorganisms. , 2015, Environmental microbiology.

[44]  Neil Hunter,et al.  Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. , 2002, Microbiology.

[45]  R. Amann,et al.  Optimizing fluorescent in situ hybridization with rRNA-targeted oligonucleotide probes for flow cytometric identification of microorganisms. , 1993, Cytometry.

[46]  F. Cordelières,et al.  A guided tour into subcellular colocalization analysis in light microscopy , 2006, Journal of microscopy.

[47]  Luke McNally,et al.  The biogeography of polymicrobial infection , 2015, Nature Reviews Microbiology.

[48]  K. Schleifer,et al.  rRNA-Targeted Oligonucleotide Probes for the Identification of Genuine and Former Pseudomonads , 1996 .

[49]  J. Heesemann,et al.  Culture independent and rapid identification of bacterial pathogens in necrotising fasciitis and streptococcal toxic shock syndrome by fluorescence in situ hybridisation , 2000, Medical Microbiology and Immunology.

[50]  N. Wellinghausen,et al.  Fluorescence In Situ Hybridization for Rapid Identification of Achromobacter xylosoxidans and Alcaligenes faecalis Recovered from Cystic Fibrosis Patients , 2006, Journal of Clinical Microbiology.

[51]  K. Schleifer,et al.  Phylogenetic Oligodeoxynucleotide Probes for the Major Subclasses of Proteobacteria: Problems and Solutions , 1992 .

[52]  Rajan P Kulkarni,et al.  Single-Cell Phenotyping within Transparent Intact Tissue through Whole-Body Clearing , 2014, Cell.

[53]  M. Firestone,et al.  Evaluating rRNA as an indicator of microbial activity in environmental communities: limitations and uses , 2013, The ISME Journal.

[54]  M. Blaser,et al.  The human microbiome: at the interface of health and disease , 2012, Nature Reviews Genetics.

[55]  M. Konstan,et al.  Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[56]  Viviana Gradinaru,et al.  Single-molecule RNA detection at depth by hybridization chain reaction and tissue hydrogel embedding and clearing , 2016, Development.

[57]  D. Newman,et al.  Trace incorporation of heavy water reveals slow and heterogeneous pathogen growth rates in cystic fibrosis sputum , 2015, Proceedings of the National Academy of Sciences.